Environmental pollution has negative health effects and biomonitoring is necessary to identify the regions, local sources, and temporal distribution of air pollution. The aim of this study was the estimation of cell viability, oxidative stress, DNA damage, cell cycle alterations and activation of histone H2A.X. Evidence is shown that γH2A.X may serve as a marker for monitoring the risk of air pollutant exposure.
This Article supports SDG 3 by estimating the burden of rheumatoid arthritis. Finding include that the rate of years lived with disability due to rheumatoid arthritis increased by 13.8% from 1990 to 2020. The authors note that outcomes including severity of disability can be improved by early diagnosis and access to DMARD therapy.

Reproductive BioMedicine Online, Available online 12 October 2023, 103600

This article ties with climate action and reproductive medicine, as it is a reflexion on healthcare carbon footprint especially the IVF laboratories.
WHO recommends dolutegravir as the preferred anchor drug for first-line and second-line HIV treatment, and is being rolled out globally. This study shows that dolutegravir is safe but clinicians should nonetheless be aware of the risk of psychiatric manifestations in children and adolescents taking the drug.
This Article supports SDG 3 by showing, through a modelling analysis, that community tenofovir, lamivudine, and dolutegravir (TLD) is likely to reduce HIV incidence and be cost-effective, thus leading to population health benefits.
This Article supports SDG 3 by showing that interventions and strategies to reduce mortality from HIV-related CNS infection in public hospitals within routine care services can substantially reduce all-cause 2-week mortality among people living with HIV presenting to public hospitals with suspected HIV-related CNS infection.

The Lancet Psychiatry, Volume 10, October 2023

This commentary describes the contributions people from minority groups with mental illness can make to mental health research.
This Article supports SDG 3 by analysing 40 studies from Latin America to find a lifetime prevalence of depressive disorder in this region of 12.6%, and a current prevalence of 3.1%. The authors note that after adjusting for income and using the same inclusion criteria and assessment methods, these estimates may be higher than global estimates provided by previous systematic reviews; however, more mental health research is needed in the region to generate more definitive conclusions.
The objective of this longitudinal study was to analyze changes in physical activity, sedentary time, sleep, anxiety, mood, and perceived health as a result of COVID-19 pandemic in a cohort of Spanish

The Lancet Child and Adolescent Health, Volume 7, September 2023

Hillis is Senior Technical Advisor at the President's Emergency Plan for AIDS Relief (PEPFAR), and Senior Research Fellow and co-chair of the Global Reference Group on Children Affected by COVID-19 at the University of Oxford, Oxford, UK.